WebApr 14, 2024 · Patient reported outcomes are being assessed with FSHD-Health Index (FSHD-HI) and patient global impression of change (PGIC). Results: Design of the Phase 2b to be presented. Conclusions: Based on supportive pre-clinical and preliminary clinical data we have designed an ongoing a phase 2b clinical trial assessing the efficacy of … WebOct 25, 2024 · The FSHD-COM correlates well with disease severity, duration, and strength. However, the FSHD-COM still needs to be validated in multicenter trials and demonstrate sensitivity to disease change . A patient-reported outcome tool, the FSHD Health Index (FSHD-HI), is currently being evaluated in a prospective study . Overall, there has been …
Mario Saporta, MD, PhD, MBA - FSHD Society
WebThe blood transcriptome was examined in relation to disease severity in type I myotonic dystrophy (DM1) patients who participated in the Observational Prolonged Trial In DM1 to Improve QoL- Standards (OPTIMISTIC) study. This sought to (a) ascertain if transcriptome changes were associated with increasing disease severity, as measured by the muscle … WebStudy of Testosterone and rHGH in FSHD Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy ... as measured by the FSHD Health Index questionnaire (FSHD-HI). Table 1. FSHD therapeutic development Tested in patients? Yes Yes Yes Yes Yes Yes Yes Yes References (101,102) (103-106) (97) … guy learning shuffling
Clinical trial readiness to solve barriers to drug development in FSHD …
WebFacioscapulohumeral muscular dystrophy is a disorder characterized by muscle weakness and wasting (atrophy). This condition gets its name from the muscles that are affected most often: those of the face (facio-), around the shoulder blades (scapulo-), and in the upper arms (humeral). The signs and symptoms of facioscapulohumeral muscular ... WebOther COAs include 1) Domain 1 of the Motor Function Measure; 2) Reachable workspace; 3) orofacial strength using the Iowa Oral Performance Instrument; 4) lean muscle mass using dual-energy X-ray absorptiometry (DEXA); 5) strength as measured by quantitative myometry and manual muscle testing; and 6) the FSHD Health Index and other patient ... WebAbsolute change from baseline in FSHD-health index (FSHD-HI, subjects from A083-02) or CMT health index (CMT-HI, subjects from A083-03) total score and subscale scores PK parameters of ACE-083 serum concentrations over time Exploratory: Percent and absolute change from baseline in biomarkers. guy leaning back speakers